Home > EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl).

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2017) EMCDDA–Europol joint report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl). Luxembourg: Publications Office of the European Union.

[img]
Preview
PDF (EMCDDA–Europol Joint Report) - Published Version
445kB

In November 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide, commonly known as furanylfentanyl, through a joint assessment. Furanylfentanyl is a synthetic opioid, closely related to fentanyl, which is likely to be a potent opioid narcotic analgesic and may have an abuse liability and dependence potential in humans. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 23 January 2017. 

Item Type:Evidence resource
Publication Type:Report
Drug Type:New psychoactive substance
Source:EMCDDA
Date:July 2017
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Substances > Opioids (opiates) > Opioid product > Fentanyl
B Substances > New (novel) psychoactive substances
E Concepts in biomedical areas > Pharmacology and toxicology
J Health care, prevention and rehabilitation > Risk and protective factors > Risk factors
VA Geographic area > Europe

Repository Staff Only: item control page